Strengths

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● The opinion of analysts covering the stock has improved over the past four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● Low profitability weakens the company.

● The group shows a rather high level of debt in proportion to its EBITDA.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.